Loading…

PHASE III RANDOMIZED STUDY OF ENZASTAURIN/R‐CHOP VS PLACEBO/R‐CHOP IN FRONTLINE HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH GENOMIC BIOMARKER DGM1 (ENGINE STUDY)

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2019-06, Vol.37 (S2), p.70-70
Main Authors:	Zhu, J., Song, Y., Smith, S.D., O'Connor, O.A., Luo, W., Shazer, R.L., Zhang, L., Han, I., Jivani, M.A., Liu, Y., Nowakowski, G.S.
Format:	Article
Language:	English
Subjects:	B-cell lymphoma Biomarkers Lymphocytes B Lymphoma
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!